UNIGE document Scientific Article
previous document  unige:98660  next document
add to browser collection
Title

Prise en charge de la carcinose péritonéale par chirurgie cytoréductive et chimiothérapie hyperthermique intrapéritonéale

Authors show hidden authors show all authors [1 - 10]
Published in Revue médicale suisse. 2016, vol. 12, no. 523, p. 1190-4
Abstract In 2016, peritoneal carcinomatosis can be considered as a chronic disease that can be treated and sometimes cured. Hyperthermic Intra PEritoneal Chemotherapy (HIPEC) is a procedure developed in the eighties. Combined with CytoReductive (CR) surgery, this protocol underwent a considerable expansion in Washington Cancer Institute. CR combined with HIPEC was demonstrated to be the only curative treatment for PseudoMyxoma Peritonei syndrome (PMP). It is actually approved in the management of peritoneal carcinomatosis of ovarian, colorectal, or peritoneal primitive (mesothelioma) origin but is still studied for gastric cancer. CR/HIPEC is associated with an important mortality and morbidity. This article takes stock of indications to CR/HIPEC.
Keywords ChemotherapyCancerRegional PerfusionCytoreduction Surgical ProceduresHumansHyperthermiaInducedPeritoneal Neoplasms/therapy
Identifiers
PMID: 27487625
Full text
Structures
Research group Chirurgie viscérale (104)
Citation
(ISO format)
BALAPHAS, Alexandre et al. Prise en charge de la carcinose péritonéale par chirurgie cytoréductive et chimiothérapie hyperthermique intrapéritonéale. In: Revue médicale suisse, 2016, vol. 12, n° 523, p. 1190-4. https://archive-ouverte.unige.ch/unige:98660

14 hits

11 downloads

Update

Deposited on : 2017-11-07

Export document
Format :
Citation style :